The invention concerns compounds of Formula (I) or pharmaceutically-acceptable salts thereof, wherein R1 and R2 have any of the meanings defined hereinbefore in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of cell proliferative disorders.
申请公布号
HK1214592(A1)
申请公布日期
2016.07.29
申请号
HK20160102484
申请日期
2016.03.04
申请人
ASTRAZENECA AB
发明人
BARLAAM, Bernard Christophe;BERRY, David;DELOUVRIE, Benedicte;HARRIS, Craig Steven;LAMBERT-VAN DER BREMPT, Christine Marie Paul;OUVRY, Gilles;REID, Gary Patrick;TOMKINSON, Gary Peter
